you are here: HomeNewsRemdesivir
remdesivir
Jump to
42 Results Found
  • Why is COVID-19 key medicine remdesivir out of stock? The US might be the culprit Jul 01, 2020 07:05 PM IST

    Why is COVID-19 key medicine remdesivir out of stock? The US might be the culprit

    This effectively means that there will be no stock left for the rest of the world in the coming months.

  • Maharashtra govt to procure large supplies of Remdesivir, Favipiravir Jun 26, 2020 07:40 AM IST

    Maharashtra govt to procure large supplies of Remdesivir, Favipiravir

    "We have decided to buy Remdesivir and Favipiravir as well as other essential drugs to treat COVID-19 patients in large numbers. The drugs are costly so the state has decided to buy them itself," he told reporters here.

  • Gilead Science's Remdesivir endorsed as first COVID-19 treatment in Europe Jun 25, 2020 09:55 PM IST

    Gilead Science's Remdesivir endorsed as first COVID-19 treatment in Europe

    The regulatory agency says it was granting a conditional marketing authorization for remdesivir to be used in treating adults and adolescents older than 12 with pneumonia who require oxygen.

  • US group raises pricing recommendation for Gilead's remdesivir in COVID-19 Jun 25, 2020 07:00 AM IST

    US group raises pricing recommendation for Gilead's remdesivir in COVID-19

    The Institute for Clinical and Economic Review (ICER) said its recommendation change stemmed from recent clinical data, updated cost estimates, public comments and interactions with Gilead.

  • COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir Jun 23, 2020 10:16 AM IST

    COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir

    Gilead Sciences says it also expects to supply remdesivir to treat more than two million COVID-19 patients by year-end.

  • Gilead targets remdesivir supply for two million COVID-19 patients by year-end Jun 23, 2020 07:10 AM IST

    Gilead targets remdesivir supply for two million COVID-19 patients by year-end

    Gilead Sciences has said it hopes to start trials in August of an easier-to-use inhaled version of remdesivir, currently administered only intravenously.

  • Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts Jun 22, 2020 08:27 PM IST

    Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

    Dr Avi Kumar, Consultant, Pulmonologist, Fortis Escort Heart Institute, said drugs such as Favipiravir and Remdisiver "cannot be called game changers" as they are used as a supportive treatment.

  • Exclusive: How did Hetero single-handedly pull off the Remdesivir challenge? Jun 22, 2020 05:26 PM IST

    Exclusive: How did Hetero single-handedly pull off the Remdesivir challenge?

    By January, when reports about use of Gilead's experimental drug Remdesivir on COVID-19 patients in China have started to surface, Hetero plunged into action to develop Remdesivir.

  • Coronavirus pandemic | Remdesivir may be 'widely available' in India by June-end: Report Jun 19, 2020 12:44 PM IST

    Coronavirus pandemic | Remdesivir may be 'widely available' in India by June-end: Report

    Competitive prices also seem more likely as domestic pharmaceutical companies claim capability to produce the drug without active pharmaceutical ingredients (API) import from China

  • Coronavirus pandemic | Maharashtra govt demands COVID-19 drugs, ventilators from Centre Jun 17, 2020 05:00 PM IST

    Coronavirus pandemic | Maharashtra govt demands COVID-19 drugs, ventilators from Centre

    "We have been issuing remdesivir and tocilizumab drugs to treat COVID-19 patients on case-to-case basis with the help of ICMR. But now we need these medicines in large numbers and at reasonable price from the Centre for treatment of patients," Maharashtra Health Minister Rajesh Tope said.

  • Coronavirus pandemic | DCGI says awaiting remdesivir safety data from local manufacturers: Report Jun 16, 2020 10:30 AM IST

    Coronavirus pandemic | DCGI says awaiting remdesivir safety data from local manufacturers: Report

    Amid delays in India, some patients have reportedly been importing the experimental antiviral drug from Bangladesh for personal use.

  • Hydroxychloroquine should be avoided in severe cases: Health Ministry Jun 13, 2020 09:17 PM IST

    Hydroxychloroquine should be avoided in severe cases: Health Ministry

    Hydroxychloroquine has demonstrated in-vitro activity against SARS-CoV2 and was shown to be clinically beneficial in several small single-centre studies though with significant limitations, it stated.

  • Remdesivir rollout to take more time as pharma firms working on providing safety, quality data Jun 13, 2020 05:29 PM IST

    Remdesivir rollout to take more time as pharma firms working on providing safety, quality data

    Four companies are still awaiting a nod from the DCGI for manufacturing and selling of remdesivir in India.

  • Coronavirus drug | Dr Reddy's inks pact with Gilead Sciences to manufacture remdesivir Jun 13, 2020 04:20 PM IST

    Coronavirus drug | Dr Reddy's inks pact with Gilead Sciences to manufacture remdesivir

    As per the non-exclusive licensing agreement, Gilead will grant Dr Reddy's Laboratories the right to register and manufacture its investigational Coronavirus drug remdesivir in 127 countries.

  • Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients Jun 11, 2020 05:41 PM IST

    Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients

    The much-touted anti-malarial drug hydroxychloroquine will continue to be used while azythromycin may be dropped from the treatment protocol, sources in the know of the developments told PTI.

  • Remdesivir approvals expedited, but potential COVID-19 drug unlikely to be available this month Jun 11, 2020 11:26 AM IST

    Remdesivir approvals expedited, but potential COVID-19 drug unlikely to be available this month

    Officials said that based on results of test reports and stability data, restricted emergency use approvals will then be given to Indian manufacturers on “rapid response basis”, as was given to Gilead Sciences.

  • Singapore approves remdesivir drug for emergency COVID-19 treatment Jun 10, 2020 03:12 PM IST

    Singapore approves remdesivir drug for emergency COVID-19 treatment

    Remdesivir is the first drug shown to be effective against the novel coronavirus in human trials, with South Korea, Japan, India and the United States having already approved the drug for emergency use.

  • Maharashtra govt will procure 10,000 vials of Remdesivir to treat COVID-19 patients: Tope Jun 06, 2020 07:01 PM IST

    Maharashtra govt will procure 10,000 vials of Remdesivir to treat COVID-19 patients: Tope

    Remdesivir has generated promising results in MERS-CoV and SARS, Maharashtra Health Minister said.

  • COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report Jun 04, 2020 10:18 AM IST

    COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report

    Gilead Sciences' experimental drug Remdesivir has been found to aid in the recovery of COVID-19 patients.

  • COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report Jun 03, 2020 09:00 AM IST

    COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report

    It is the only drug so far that has shown significant effect on patients infected with COVID-19.

  • India approves emergency use of remdesivir to treat COVID-19 patients Jun 02, 2020 08:34 PM IST

    India approves emergency use of remdesivir to treat COVID-19 patients

    The drug was granted emergency use authorization by the U.S. Food and Drug Administration last month and has received approval by Japanese health regulators.

  • Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions Jun 02, 2020 04:46 PM IST

    Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions

    Remdesivir is the only drug so far that has been shown to help patients with COVID-19, but Gilead and other companies are looking for ways to make it work better.

  • Gilead says remdesivir helped moderate COVID-19 patients improve Jun 01, 2020 06:58 PM IST

    Gilead says remdesivir helped moderate COVID-19 patients improve

    At Day 11, a higher proportion of patients in the 5-day treatment group achieved improvement in clinical status versus the standard of care group, Gilead said.

  • BDR Pharmaceuticals seeks drug controller’s nod to manufacture generic version of Remdesivir, irks Gilead: Report May 28, 2020 10:16 AM IST

    BDR Pharmaceuticals seeks drug controller’s nod to manufacture generic version of Remdesivir, irks Gilead: Report

    Raising concerns, Gilead has reportedly written to the Prime Minister’s Office, the Union Health Ministry and NITI Aayog, among others.

  • Several drugs under trial for COVID-19, remdesivir leading contender: Scientists May 23, 2020 04:15 PM IST

    Several drugs under trial for COVID-19, remdesivir leading contender: Scientists

    As COVID-19 continues its spread -- crossing 5.2 million cases and 3,38,000 fatalities on Saturday -- several categories of drugs are under clinical trial.

Sections